By targeting both GLP-1 and GIP receptors, it offers a dual-action approach that delivers superior blood sugar control and substantial weight losstwo key goals in managing metabolic disease
Mendelsohn noted that the agreement with Novo is not a licensing deal, but said it's a "good validation for where we are and where this product could ultimately end up." For now, doctors say several important questions remain unanswered, but also acknowledge the potential of the treatment
Someone who is anorexic is much more likely to have a heart attack and far more likely to have cholesterol issues because of that condition. A few other situations dont rule you out automatically, but they do call for extra caution and a real conversation: a history of gallbladder disease, diabetic retinopathy (rapid weight loss can temporarily make it worse), and any history of an eating disorder, which warrants screening before treatment starts
The immune response to SARS-CoV-2 in the respiratory tract has been shown to induce neuroinflammation, which subsequently leads to an acute inflammatory response and immune cell trafficking in the brain, and induces reactive states of resident microglia and other immune cells in the brain and brain borders [44, 51, 154]
.png)
